Molecular Diagnostics-EMEA Market Status and Trend Report 2013-2023
SKU ID :MI-10907230 | Published Date: 28-Jan-2018 | No. of pages: 157Description
TOC
Table of Contents
Chapter 1 Overview of Molecular Diagnostics
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 Infectious Disease
1.2.2 Oncology
1.2.3 Genetics
1.2.4 Microbiology
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Hospital
1.3.2 Laboratories
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 EMEA Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
Chapter 2 EMEA Market Status and Forecast by Regions
2.1 Market Status of Molecular Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Molecular Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in EMEA by Regions
2.2.2 Revenue of Molecular Diagnostics in EMEA by Regions
2.3 Market Analysis of Molecular Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Molecular Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
Chapter 3 EMEA Market Status and Forecast by Types
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in EMEA by Types
3.1.2 Revenue of Molecular Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Molecular Diagnostics in EMEA by Types
Chapter 4 EMEA Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Molecular Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Molecular Diagnostics in EMEA by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Molecular Diagnostics
5.1 EMEA Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
Chapter 6 Molecular Diagnostics Market Competition Status by Major Players in EMEA
6.1 Sales Volume of Molecular Diagnostics in EMEA by Major Players
6.2 Revenue of Molecular Diagnostics in EMEA by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Molecular Diagnostics Major Manufacturers Introduction and Market Data
7.1 Roche Diagnostics
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.2 QIAGEN N.V.
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.3 Hologic Inc
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.4 Grifols
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Siemens Healthcare
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.7 Becton, Dickinson
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson
7.8 Beckman Coulter
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.9 bioMérieux SA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioMérieux SA
7.10 Cepheid
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
Chapter 8 Upstream and Downstream Market Analysis of Molecular Diagnostics
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Molecular Diagnostics
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
Chapter 10 Marketing Status Analysis of Molecular Diagnostics
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Infectious Disease
Table Advantage and Disadvantage of Oncology
Table Advantage and Disadvantage of Genetics
Table Advantage and Disadvantage of Microbiology
Table Consumption Volume of Molecular Diagnostics in EMEA by Regions 2013-2017
Table Revenue of Molecular Diagnostics in EMEA by Regions 2013-2017
Table Consumption Volume of Molecular Diagnostics in EMEA by Regions 2018-2023
Table Revenue of Molecular Diagnostics in EMEA by Regions 2018-2023
Table Consumption Volume of Molecular Diagnostics in EMEA by Types 2013-2017
Table Revenue of Molecular Diagnostics in EMEA by Types 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in Europe 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in Middle East 2013-2017
Table Consumption Volume of Molecular Diagnostics by Types in Africa 2013-2017
Table Consumption Volume Forecast of Molecular Diagnostics in EMEA by Types 2018-2023
Table Revenue Forecast of Molecular Diagnostics in EMEA by Types 2018-2023
Table Demand Volume of Molecular Diagnostics in EMEA by Downstream Industry 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in Europe 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in Middle East 2013-2017
Table Demand Volume of Molecular Diagnostics by Downstream Industry in Africa 2013-2017
Table Demand Volume Forecast of Molecular Diagnostics in EMEA by Downstream Industry 2018-2023
Table Sales Volume of Molecular Diagnostics in EMEA by Major Players 2013-2017
Table Revenue of Molecular Diagnostics in EMEA by Major Players 2013-2017
Table Headquarters Location and Established Time of Molecular Diagnostics Major Players
Table Employees and Revenue Level of Molecular Diagnostics Major Players
Table Representative Molecular Diagnostics Product One of Roche Diagnostics
Table Representative Molecular Diagnostics Product Two of Roche Diagnostics
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017
Table Representative Molecular Diagnostics Product One of QIAGEN N.V.
Table Representative Molecular Diagnostics Product Two of QIAGEN N.V.
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V. 2013-2017
Table Representative Molecular Diagnostics Product One of Hologic Inc
Table Representative Molecular Diagnostics Product Two of Hologic Inc
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc 2013-2017
Table Representative Molecular Diagnostics Product One of Grifols
Table Representative Molecular Diagnostics Product Two of Grifols
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols 2013-2017
Table Representative Molecular Diagnostics Product One of Abbott Laboratories
Table Representative Molecular Diagnostics Product Two of Abbott Laboratories
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017
Table Representative Molecular Diagnostics Product One of Siemens Healthcare
Table Representative Molecular Diagnostics Product Two of Siemens Healthcare
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare 2013-2017
Table Representative Molecular Diagnostics Product One of Becton, Dickinson
Table Representative Molecular Diagnostics Product Two of Becton, Dickinson
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson 2013-2017
Table Representative Molecular Diagnostics Product One of Beckman Coulter
Table Representative Molecular Diagnostics Product Two of Beckman Coulter
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter 2013-2017
Table Representative Molecular Diagnostics Product One of bioMérieux SA
Table Representative Molecular Diagnostics Product Two of bioMérieux SA
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioMérieux SA 2013-2017
Table Representative Molecular Diagnostics Product One of Cepheid
Table Representative Molecular Diagnostics Product Two of Cepheid
Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017
Companies
- PRICE
-
$3480$5980